- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04864041
Evaluation of Left Ventricular Function by Speckle Tracking Echocardiography in Patient Hospitalised in Intensive Care Unit for Vaso-occlusive Crisis
April 27, 2021 updated by: Xavier Monnet, Bicetre Hospital
Vaso-occlusive crisis in Sickle cell disease might alter myocardial function through micro vascular obstruction.
Evaluation of strain alteration using speckle tracking echocardiography is a non invasive technique that may allow us to observe such myocardial dysfunction.
No such study has yet been conducted in patient hospitalised in intensive care unit.
Our hypothesis is that strain alteration during vaso-occlusive crisis, if they do exist, can be correlated with other markers of myocardial injury such as troponin level or thoracic pain.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xavier Monnet, MD, PhD
- Phone Number: 00331 45 21 35 39
- Email: xavier.monnet@aphp.fr
Study Locations
-
-
-
Le Kremlin-Bicêtre, France
- Recruiting
- Medical Intensive Care Unit
-
Contact:
- Xavier Monnet, MD, PhD
- Phone Number: 00331 45 21 35 39
- Email: xavier.monnet@aphp.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patient with vaso occlusive crisis hospitalised in an intensive care unit.
Description
Inclusion Criteria:
- Hospitalisation in an intensive care unit for vaso-occlusive crisis
Exclusion Criteria:
- Pregnancy
- Individuals under guardianship
- Unsufficient echogenicity
- Thoracic pain prohibiting echocardiography assessment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients hospitalised in ICU for vaso-occlusive crisis
|
There are no particular intervention performed in patients in this study, because echocardiography is part of the standard of care of patients hospitalised in the ICU for vaso occlusive crisis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Global longitudinal strain
Time Frame: Day 0
|
Measure of global longitudinal strain using speckle tracking echocardiography
|
Day 0
|
|
Global longitudinal strain
Time Frame: Day 1
|
Measure of global longitudinal strain using speckle tracking echocardiography
|
Day 1
|
|
Global longitudinal strain
Time Frame: Day 2
|
Measure of global longitudinal strain using speckle tracking echocardiography
|
Day 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Troponine level
Time Frame: Day 0
|
Day 0
|
|
|
Troponine level
Time Frame: Day 1
|
Day 1
|
|
|
Troponine level
Time Frame: Day 2
|
Day 2
|
|
|
Electrocardiogram QT interval
Time Frame: Day 0
|
Day 0
|
|
|
Electrocardiogram QT interval
Time Frame: Day 2
|
Day 2
|
|
|
Electrocardiogram ST elevation
Time Frame: Day 0
|
Day 0
|
|
|
Electrocardiogram ST elevation
Time Frame: Day 2
|
Day 2
|
|
|
Electrocardiogram negative T waves
Time Frame: Day 0
|
Day 0
|
|
|
Electrocardiogram negative T waves
Time Frame: Day 2
|
Day 2
|
|
|
Thoracic pain
Time Frame: Day 0
|
Numerical rating scale from 0 to 10 assessed by the patient
|
Day 0
|
|
Thoracic pain
Time Frame: Day 1
|
Numerical rating scale from 0 to 10 assessed by the patient
|
Day 1
|
|
Thoracic pain
Time Frame: Day 2
|
Numerical rating scale from 0 to 10 assessed by the patient
|
Day 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
April 23, 2021
First Submitted That Met QC Criteria
April 24, 2021
First Posted (Actual)
April 28, 2021
Study Record Updates
Last Update Posted (Actual)
April 29, 2021
Last Update Submitted That Met QC Criteria
April 27, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-A00623-38
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sickle Cell Disease
-
Connecticut Children's Medical CenterChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsNot yet recruitingSickle Cell Disease | Sickle Cell Disease (SCD) | Sickle Cell Anemia in Children | Sickle Cell | Sickle Cell Anemia (HbSS)United States
-
Klein Buendel, Inc.National Institute on Minority Health and Health Disparities (NIMHD); Hilton...CompletedSickle Cell Disease | Sickle Cell Anemia in Children | Sickle Cell Thalassemia | Sickle Cell SC DiseaseUnited States
-
Nova Laboratories LimitedCompletedSickle Cell Disease | Sickle Cell Hemoglobin C | Sickle Cell-beta-thalassemia | Sickle-Cell; Hemoglobin Disease, ThalassemiaUnited Kingdom, Jamaica
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedSickle Cell Disease | Sickle Cell SC Disease | Sickle Cell-SS Disease | Sickle Cell RetinopathyNetherlands
-
SangartWithdrawnSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseFrance, United Kingdom, Netherlands, Turkey, Bahrain, Belgium, Brazil, Lebanon, Qatar
-
SangartCompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseUnited Kingdom, France, Jamaica, Lebanon
-
University of British ColumbiaCompletedSickle Cell Disease | Beta-Thalassemia | Sickle Cell Trait | Sickle Cell-Beta Thalassemia | Sickle Cell-SS DiseaseCanada, Nepal
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Heart, Lung, and Blood Institute (NHLBI)TerminatedSickle Cell Anemia | Sickle Cell-hemoglobin C Disease | Sickle Cell-β0-thalassemiaUnited States
-
University of RegensburgRecruitingSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | HbS Disease | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin SGermany, Austria
-
Centre Hospitalier Intercommunal CreteilRecruitingSickle-Cell Disease Nos With CrisisFrance
Clinical Trials on Evaluation of global longitudinal strain using routinely recorded echocardiography images
-
I.M. Sechenov First Moscow State Medical UniversityCompletedCardiotoxicityRussian Federation
-
Clinical Hospital Center RijekaUniversity of Rijeka, Medical FacultyRecruitingAortic Stenosis | Permanent Pacemaker Implantation | Conduction Disorder | TAVI(Transcatheter Aortic Valve Implantation)Croatia
-
Hospital 9 de Julio de Las BreñasInstituto de Cardiología de CorrientesRecruitingHereditary Amyloidosis, Transthyretin-RelatedArgentina
-
Samara State Medical UniversityRecruitingEndothelial Dysfunction | Cardiotoxicity | Acute Myeloid Leukemia, AdultRussian Federation